Late clinical outcomes for SeQuent please paclitaxel‐coated balloons in PCI of instent restenosis and de novo lesions: A single‐center, real world registry

Abstract

MACE rates were acceptable, with overall low incidence of cardiac death, MI, and TLR, for PCB treatment of ISR and DNL. Independent predictors of poor outcome in the ISR group were DM and prior CABG. The particularly low MACE for the DNL group supports direct PCB as a viable stent-sparing PCI strategy in challenging patients and lesion subsets. © 2016 Wiley Periodicals, Inc.